Jump to navigation
STEM CELLS | STEM CELLS Translational Medicine
Selecting cells with high inherent reprogramming potential via CAG promoter activity represents a possible means to improve reprogramming efficiency
Synthetic mRNA‐induced differentiation may accelerate our understanding of Parkinson's disease development in GD1 patients
A new review summarizes advances in iPSC‐based modeling to explore glial cell involvement in neurodegenerative diseases
iPSC-derived AMD model used to investigate the interplay between lysosome function and complement activation in the hope of identifying therapeutic targets
The miR‐183/96/182 cluster controls retinal tissue morphogenesis and represents an important regulator of PAX6 expression
Modulating the miR‐184/Wnt3 pathway in embryonic stem cells may provide for the development of efficient cell therapies for the damaged heart
CDK8/19 Mediator components control pluripotent stem cell differentiation and self-renewal and regulate preimplantation naïve epiblast gene expression
Kanagaki et al. underscore the potential utility of iPSC-derived AT1cells in understanding their differentiation from AT2 cells in vitro.
A review summarizes in vitro models used in aortic disease research and provides guidance for the development of advanced models using iPSCs
New research identifies differences in the global chromatin landscape that occur during the cellular reprogramming of canine cells
The Stem Cells Portal is a shared platform for the STEM CELLS and STEM CELLS Translational Medicine sister journals, providing up-to-the-minute coverage of the latest research from bench science and developments to clinical applications.
Copyright © 2021